| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.12 | 0.02 |